Abstract
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ
PLoS Med. 2008;5
Permenent descriptor
https://doi.org/10.1371/journal.pmed.0050227
No abstract available
